Skip to main content
. Author manuscript; available in PMC: 2018 Aug 22.
Published in final edited form as: JPEN J Parenter Enteral Nutr. 2016 Sep 22;41(8):1325–1335. doi: 10.1177/0148607116670377

Table 2.

Admission Characteristics by Treatment Received and Immune Status: Immune Competent Without Lymphopenia.

Characteristic WHEY (n = 60) ZSGM (n = 74) P Value
Age, median (range), y 5.1 (1–18) 5.2 (1–18) .53a
Female (%) 58 39 .03b
Weight-for-age percentile, median (range) 34 (0–100) n = 54 52 (0–100) n = 71 .15a
Height-for-age percentile, median (range) 13 (0–100) 46 (0–100) .07a
BMI-for-age percentile, median (range) 72 (0–100) 64 (0–100) .47a
PELOD, median (range) 11 (0–31) 11 (1–50) .55a
PRISM, median (range) 8 (0–27) 7 (0–31) .87a
OFI, median (range) 2 (0–5) 2 (0–6) .78a
Postoperative PICU admit, % 22 27 .47b
Primary diagnosis, % .04c
    Asthma 2 0
    Cardiac arrest 2 4
    Cardiovascular disease—acquired 0 1
    Cardiovascular disease—congenital 5 4
    Drug overdose 2 0
    Meningitis 2 1
    Pneumonia/bronchiolitis 33 16
    Seizures 2 5
    Sepsis 8 7
    Shock 5 0
    Trauma 12 30
    Other 28 31
Chronic diagnoses, % 48 45 .67b
Infection status at entry, % .055b
    Existing infection 43 39
    Existing sepsis 37 23
    No infection or sepsis 20 38

BMI, body mass index; HIV, human immunodeficiency virus; OFI, Organ Failure Index; PELOD, Pediatric Logistic Organ Dysfunction score; PICU, pediatric intensive care unit; PRISM, Pediatric Risk of Mortality; WHEY, whey protein powder and intravenous saline group; ZSGM, zinc, selenium, glutamine, and metoclopramide group.

a

P value is based on the Wilcoxon rank-sum test for continuous/ordinal characteristics.

b

P value is based on the Pearson X test for categorical characteristics.

c

P value is based on the Fisher exact test for categorical characteristics.